Risa Fujii

656 citations
16 papers · 449 indexed · h-index 9
Topics
Extracellular vesicles in disease (7 papers)MicroRNA in disease regulation (4 papers)Glycosylation and Glycoproteins Research (3 papers)
Partner nations
JapanUnited States

In The Last Decade

Risa Fujii

16 papers receiving 443 citations

Peers

Risa Fujii
Comparison fields: 5 of 74
  • Molecular Biology 344
  • Cancer Research 191
  • Immunology 71
  • Pulmonary and Respiratory Medicine 44
  • Biomedical Engineering 39
Replace Koushik Muralidharan with:
Koushik Muralidharan United States
Junfeng Zhang China
Ariana von Lersner United States
Laura Bronsart United States
Hongchen Cai United States
Yu-Ting Su Taiwan
Alena Bartáková United States
Basant Kumar Thakur Germany
Simon Kling Germany
Zied Boudhraa France
Risa Fujii relative to Koushik Muralidharan United States Koushik Muralidharan's profile →
Citations per field
00.5×10×20×30×36×
Koushik Muralidharan · 1×
Citations per year

Countries citing papers authored by Risa Fujii

Since Specialization
Citations

This map shows the geographic impact of Risa Fujii's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Risa Fujii with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Risa Fujii more than expected).

Fields of papers citing papers by Risa Fujii

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Risa Fujii. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Risa Fujii. The network helps show where Risa Fujii may publish in the future.

Co-authorship network of co-authors of Risa Fujii

This figure shows the co-authorship network connecting the top 25 collaborators of Risa Fujii. A scholar is included among the top collaborators of Risa Fujii based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Risa Fujii. Risa Fujii is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
#WorkIndexed citations
1 4
2 9
3 17
4 3
5 14
6 5
7 5
8 7
9 29
10 8
11 10
12 66
13 73
14 29
15 3
16 167

About Risa Fujii

Risa Fujii is a scholar working on Cancer Research, Molecular Biology and Immunology, having authored 16 papers that have together received 449 indexed citations. Recurring topics across this work include Extracellular vesicles in disease (7 papers), MicroRNA in disease regulation (4 papers) and Glycosylation and Glycoproteins Research (3 papers). The work is most often cited by research in Cancer Research (191 citations), Molecular Biology (344 citations) and Immunology and Allergy (21 citations). Risa Fujii has collaborated with scholars based in Japan and United States. Frequent co-authors include Koji Ueda, Naomi Saichi, Ayako Tatsuguchi, Hidewaki Nakagawa, Nobuhisa Ishikawa, Kazutoshi Fujita, Naomi Ohnishi, Motohide Uemura, Wataru Nakata and Kentaro Jingushi. Their work appears in journals such as Journal of Biological Chemistry, Nature Communications and PLoS ONE.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026